These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 28092195)
1. Serum BDNF levels in patients with gambling disorder are associated with the severity of gambling disorder and Iowa Gambling Task indices. Choi SW; Shin YC; Mok JY; Kim DJ; Choi JS; Suk-Hyun Hwang S J Behav Addict; 2016 Mar; 5(1):135-139. PubMed ID: 28092195 [TBL] [Abstract][Full Text] [Related]
2. EEG correlates associated with the severity of gambling disorder and serum BDNF levels in patients with gambling disorder. Kim KM; Choi SW; Lee J; Kim JW J Behav Addict; 2018 Jun; 7(2):331-338. PubMed ID: 29865867 [TBL] [Abstract][Full Text] [Related]
3. Altered serum levels of brain-derived neurotrophic factor in patients with pathological gambling. Geisel O; Banas R; Hellweg R; Müller CA Eur Addict Res; 2012; 18(6):297-301. PubMed ID: 22854676 [TBL] [Abstract][Full Text] [Related]
4. Enhanced BDNF serum levels in patients with severe pathological gambling. Angelucci F; Martinotti G; Gelfo F; Righino E; Conte G; Caltagirone C; Bria P; Ricci V Addict Biol; 2013 Jul; 18(4):749-51. PubMed ID: 22044515 [TBL] [Abstract][Full Text] [Related]
5. Relationships between brain-derived neurotrophic factor, clinical symptoms, and decision-making in chronic schizophrenia: data from the Iowa Gambling Task. Hori H; Yoshimura R; Katsuki A; Atake K; Nakamura J Front Behav Neurosci; 2014; 8():417. PubMed ID: 25538582 [TBL] [Abstract][Full Text] [Related]
6. Decision making measured by the Iowa Gambling Task in alcohol use disorder and gambling disorder: a systematic review and meta-analysis. Kovács I; Richman MJ; Janka Z; Maraz A; Andó B Drug Alcohol Depend; 2017 Dec; 181():152-161. PubMed ID: 29055269 [TBL] [Abstract][Full Text] [Related]
7. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine. Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053 [TBL] [Abstract][Full Text] [Related]
8. Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: as a biological predictor of response to group cognitive behavioral therapy. Kobayashi K; Shimizu E; Hashimoto K; Mitsumori M; Koike K; Okamura N; Koizumi H; Ohgake S; Matsuzawa D; Zhang L; Nakazato M; Iyo M Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):658-63. PubMed ID: 15905010 [TBL] [Abstract][Full Text] [Related]
9. Iowa Gambling Task scores predict future drug use in bipolar disorder outpatients with stimulant dependence. Nejtek VA; Kaiser KA; Zhang B; Djokovic M Psychiatry Res; 2013 Dec; 210(3):871-9. PubMed ID: 24012163 [TBL] [Abstract][Full Text] [Related]
10. Serum brain-derived neurotrophic factor level in relation to illness severity and episode duration in patients with major depression. Birkenhäger TK; Geldermans S; Van den Broek WW; van Beveren N; Fekkes D J Psychiatr Res; 2012 Mar; 46(3):285-9. PubMed ID: 22244515 [TBL] [Abstract][Full Text] [Related]
11. Illness severity and biomarkers in depression: Using a unidimensional rating scale to examine BDNF. Caldieraro MA; Vares EA; Souza LH; Spanemberg L; Guerra TA; Wollenhaupt-Aguiar B; Ferrari P; Nierenberg AA; Fleck MP Compr Psychiatry; 2017 May; 75():46-52. PubMed ID: 28301802 [TBL] [Abstract][Full Text] [Related]
12. Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder. Dias VV; Brissos S; Frey BN; Andreazza AC; Cardoso C; Kapczinski F Bipolar Disord; 2009 Sep; 11(6):663-71. PubMed ID: 19689509 [TBL] [Abstract][Full Text] [Related]
13. Influence of BDNF and COMT polymorphisms on emotional decision making. Kang JI; Namkoong K; Ha RY; Jhung K; Kim YT; Kim SJ Neuropharmacology; 2010 Jun; 58(7):1109-13. PubMed ID: 20153759 [TBL] [Abstract][Full Text] [Related]
14. Brain-derived neurotrophic factor serum levels in heroin-dependent patients after 26weeks of withdrawal. Zhang K; Jiang H; Zhang Q; Du J; Wang Y; Zhao M Compr Psychiatry; 2016 Feb; 65():150-5. PubMed ID: 26774004 [TBL] [Abstract][Full Text] [Related]
15. Brain-derived neurotrophic factor in substance use disorders: A systematic review and meta-analysis. Ornell F; Hansen F; Schuch FB; Pezzini Rebelatto F; Tavares AL; Scherer JN; Valerio AG; Pechansky F; Paim Kessler FH; von Diemen L Drug Alcohol Depend; 2018 Dec; 193():91-103. PubMed ID: 30347311 [TBL] [Abstract][Full Text] [Related]
16. Serum brain-derived neurotrophic factor level in elderly women depression: a community-based study. Hashizume M; Hachisu M; Yoshida H; Kim M; Kim HK; Amano Y; Hasegawa C; Suzuki T; Ihara K Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():109-16. PubMed ID: 25178999 [TBL] [Abstract][Full Text] [Related]
17. Decision Making Impairment: A Shared Vulnerability in Obesity, Gambling Disorder and Substance Use Disorders? Mallorquí-Bagué N; Fagundo AB; Jimenez-Murcia S; de la Torre R; Baños RM; Botella C; Casanueva FF; Crujeiras AB; Fernández-García JC; Fernández-Real JM; Frühbeck G; Granero R; Rodríguez A; Tolosa-Sola I; Ortega FJ; Tinahones FJ; Alvarez-Moya E; Ochoa C; Menchón JM; Fernández-Aranda F PLoS One; 2016; 11(9):e0163901. PubMed ID: 27690367 [TBL] [Abstract][Full Text] [Related]
18. No change between the serum brain-derived neurotrophic factor in female patients with anorexia nervosa before and after partial weight recovery. Nakazato M; Hashimoto K; Yoshimura K; Hashimoto T; Shimizu E; Iyo M Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1117-21. PubMed ID: 16753247 [TBL] [Abstract][Full Text] [Related]
19. Altered serum level of matrix metalloproteinase-9 and its association with decision-making in eating disorders. Matsumoto J; Hirano Y; Hashimoto K; Ishima T; Kanahara N; Niitsu T; Shiina A; Hashimoto T; Sato Y; Yokote K; Murano S; Kimura H; Hosoda Y; Shimizu E; Iyo M; Nakazato M Psychiatry Clin Neurosci; 2017 Feb; 71(2):124-134. PubMed ID: 27891714 [TBL] [Abstract][Full Text] [Related]